M K Proteins Ltd

M K Proteins Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

M K Proteins Ltd

₹ 5.26 -0.19%
13 Feb - close price
Company website BSE: 543919 NSE: MKPL
About

Incorporated in 2012, M K Proteins Ltd is engaged in manufacturing, trading, and production of Edible Oils[1]

Key Points

Business Overview:[1][2]
a) MKPL is a Rajkot based partnership firm promoted by Keshariya and Mashru family. It is a part of the Shree Ganesh Fats Group
b) Company is engaged in processing and manufacturing of groundnut refined oil, groundnut oil cake and ground nut seeds
c) It produces rice bran oil, sunflower oil with protein content, with controlled fibre free from oil residue, ash and sand & silica
d) Company's manufacturing process involves refining of Crude Oils to obtain Refined Rice Bran Oil, Canola Oil, Soya Bean Oil, Sunflower Oil and Rice Bran Bleached Oil. During the refining process certain by-products are also manufactured, viz. Rice Bran Fatty Acid Oil, Rice Bran Wax, Gums and Spent Earth which are also saleable
e) Further, it imports crude oils,
process them and sell the finished
product
f) Company also trades in both
edible and non-edible oils.

Website BSE NSE
  • Market Cap ₹ 197 Cr.
  • Current Price ₹ 5.26
  • High / Low ₹ 9.78 / 4.51
  • Stock P/E 23.3
  • Book Value ₹ 1.96
  • Dividend Yield 0.00 %
  • ROCE 12.9 %
  • ROE 12.4 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 6.64% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Agricultural Food & other Products Edible Oil

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2017 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
53.59 76.20 13.64 68.86 86.87 57.33 33.69 39.48 137.20 114.95 32.43 89.56
51.69 72.21 13.00 65.30 78.44 53.59 31.46 37.69 132.55 109.44 31.39 87.19
Operating Profit 1.90 3.99 0.64 3.56 8.43 3.74 2.23 1.79 4.65 5.51 1.04 2.37
OPM % 3.55% 5.24% 4.69% 5.17% 9.70% 6.52% 6.62% 4.53% 3.39% 4.79% 3.21% 2.65%
0.01 0.00 0.03 0.01 0.41 0.00 0.21 0.25 0.02 0.00 0.12 0.02
Interest 0.69 0.52 0.04 0.11 0.40 0.33 0.03 0.07 0.67 0.70 0.06 0.30
Depreciation 0.30 0.12 0.12 0.12 0.18 0.07 0.07 0.11 0.09 0.10 0.11 0.12
Profit before tax 0.92 3.35 0.51 3.34 8.26 3.34 2.34 1.86 3.91 4.71 0.99 1.97
Tax % 36.96% 25.67% 21.57% 25.75% 29.42% 25.45% 25.21% 25.81% 28.64% 25.27% 25.25% 26.90%
0.57 2.49 0.41 2.48 5.83 2.48 1.74 1.38 2.80 3.51 0.75 1.43
EPS in Rs 0.02 0.07 0.01 0.07 0.16 0.07 0.05 0.04 0.07 0.09 0.02 0.04
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
122 123 145 165 172 157 194 311 256 315 245 268 374
119 119 141 160 166 152 189 295 240 298 229 255 361
Operating Profit 3 4 4 5 6 5 5 16 16 17 17 13 14
OPM % 2% 3% 3% 3% 3% 3% 2% 5% 6% 5% 7% 5% 4%
0 0 0 0 0 0 0 0 0 1 0 0 0
Interest 2 2 2 2 2 2 2 1 1 2 1 1 2
Depreciation 0 1 1 1 1 1 1 1 1 1 1 0 0
Profit before tax 1 1 1 2 2 2 2 14 14 15 15 11 12
Tax % 33% 32% 31% 35% 35% 28% 26% 27% 27% 27% 28% 27%
0 1 1 1 1 2 2 10 10 11 11 8 8
EPS in Rs 0.82 1.40 1.20 0.04 0.04 0.04 0.05 0.28 0.27 0.29 0.30 0.22 0.22
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 8%
5 Years: 7%
3 Years: 2%
TTM: 72%
Compounded Profit Growth
10 Years: 25%
5 Years: 35%
3 Years: -7%
TTM: -26%
Stock Price CAGR
10 Years: %
5 Years: 43%
3 Years: -40%
1 Year: -25%
Return on Equity
10 Years: 21%
5 Years: 23%
3 Years: 18%
Last Year: 12%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.68 0.68 0.68 3 4 4 4 4 4 13 38 38 38
Reserves 1 2 3 2 11 13 15 25 35 37 24 32 36
28 20 26 31 33 26 31 25 37 46 20 39 2
2 13 10 12 8 4 7 13 10 8 15 22 4
Total Liabilities 32 35 39 47 56 47 57 67 86 103 96 131 80
3 6 7 7 6 4 3 2 3 3 3 4 3
CWIP 3 0 0 0 0 0 0 0 0 0 6 7 7
Investments 0 0 0 0 0 0 0 0 0 0 0 0 4
26 29 32 40 50 43 53 65 83 100 88 120 66
Total Assets 32 35 39 47 56 47 57 67 86 103 96 131 80

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-5 11 -4 -4 -12 6 -4 6 -10 -6 32 -16
-3 -0 -2 -1 -0 0 0 -0 -2 0 -6 -1
8 -10 6 5 12 -7 4 -5 12 6 -27 18
Net Cash Flow -0 -0 0 -0 0 -0 0 -0 0 0 0 -0

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 19 16 27 10 39 25 18 24 42 19 5 2
Inventory Days 62 70 57 83 69 75 79 48 80 91 134 170
Days Payable 6 39 22 23 12 6 8 10 8 6 19 29
Cash Conversion Cycle 75 47 62 70 97 94 89 62 114 104 120 142
Working Capital Days 69 11 9 20 44 32 36 36 55 57 77 81
ROCE % 10% 14% 13% 12% 11% 8% 8% 29% 23% 20% 19% 13%

Shareholding Pattern

Numbers in percentages

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
74.82% 74.82% 74.82% 74.82% 74.83% 74.83% 74.83% 74.82% 74.82% 74.82% 74.82% 74.82%
0.00% 0.00% 0.00% 0.00% 0.02% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
25.18% 25.17% 25.17% 25.18% 25.16% 25.15% 25.17% 25.18% 25.17% 25.18% 25.17% 25.18%
No. of Shareholders 1503441,4546,58737,28936,01843,39555,88267,75471,65672,29471,538

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings